Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
patients experiencing significant nausea may inadvertently reduce caloric intake more substantially, though this is not a sustainable or recommended approach to weight management
GLP-1s Are Already Used by More People with AUD Than Legacy SUD Treatments Crucially, GLP-1s already have an established history of use in patients with substance use disorders, simply because such a large percentage of the population is taking a GLP-1 for other conditions
Glucagon-like peptide-1 receptor agonists also lead to satiety and appetite reduction through action on the brains appetite regulation centers, leading to weight loss in obese patients
So not only do you lose more weight, you also improve your health
Get in touch to book today
